Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: Physiol Res. 2015 Jun 5;64(6):857–873. doi: 10.33549/physiolres.932977

Figure 7.

Figure 7

Heart weight/body weight ratio (a), cardiac output (b), left ventricular fractional shortening (c) and heart rate (d) in untreated sham-operated Hannover Sprague-Dawley (HanSD + water) rats, in HanSD rats treated with soluble epoxide hydrolase inhibitor (sEHi) (HanSD + sEHi), in HanSD rats treated with angiotensin-converting enzyme inhibitor (ACEi) (HanSD + ACEi), in untreated HanSD rats with aorto-caval fistula (ACF HanSD + water), in ACF HanSD rats treated with sEHi (ACF HanSD + sEHi) and in ACF HanSD rats treated with ACEi (ACF HanSD + ACEi). * P<0.05 compared with HanSD + water.